As the Michelson Medical Research Foundation and the Human Vaccines Project gear up to announce the latest winners of the 2021 Michelson Prizes on January 25, the 2018 winners discuss how receiving the prize has been instrumental in advancing their groundbreaking...
Fish that glow; a tailor-made microscope; a new way to catalog science. After six years, researchers at the USC Michelson Center for Convergent Bioscience produce the first snapshots of memory in a living animal. This article was published on USC...
The Michelson Philanthropies network published more than 230 articles in 2021, far more than in years past. Articles that highlight where our work has had a direct impact were very popular among our readers this year. Here are the top 10 most read stories from each...
Dr. Gary Michelson makes the case for why increased fast-tracking of funding and development for innovative scientific developments is key for our future in the latest COVID-19 edition of the National Academy of Inventors’ Technology & Innovation Journal. ...
New Cutting-Edge Cryo-Electron Microscopy Facility Exemplifies USC Michelson Center’s Vision for Convergent Bioscience. By Justin Chapman A new facility recently opened in the USC Michelson Center on Convergent Bioscience (MCCB) that allows scientists to...
GIBLIB, one of the companies in Michelson 20MM Foundation’s impact investment portfolio, received a special mention in TIME Magazine’s “Best Inventions of 2021” list on November 10. By Justin Chapman Congratulations to GIBLIB, one of the companies in...
Michelson Philanthropies is an organizational umbrella overseeing various initiatives and programs, including Michelson 20MM, Michelson Medical Research Foundation, and Michelson Found Animals. By Justin Chapman Veteran journalist Jerry Sullivan recapped the...
The FDA Modernization Act of 2021 marks a major milestone in transforming the biomedical sciences to embrace testing platforms that are more innovative and relevant to human health than the animal testing platforms. This article was originally published...
Cancer is not an easy target, writes Dr. Peter Kuhn, founding director of the USC Michelson Convergent Science Institute in Cancer. It consists of a disease spectrum that ranges from high lethality that is spreading rapidly to locally confined malignancies without...
This state-of-the-art MRI machine produces better, faster, and less expensive images of the human body, thus improving the capability of diagnostic imaging to detect diseases. By Justin Chapman The state-of-the-art magnetic resonance imaging (MRI)...
Dr. Wayne Koff, founder and CEO of the Human Immunome Project, discusses the origin of the Michelson Prizes, and Phillip Kim, CEO of Michelson 20MM Foundation, provides an update on the organization’s recent impact venture investments that aim to make the world a...
The Michelson Philanthropies team is growing! We’re pleased to announce new staff members Vania Campos, Justin Chapman, and Michele Morris. Vania Campos is the new Marketing Administrative Assistant at Michelson Philanthropies. In this role, she supports...